Normalization of Airflow Obstruction with Extra Fine Beclomethasone Dipropionate, Formoterol Fumarate, and Glycopyrronium Bromide (BDP/FF/GB) pMDI: A Post-Hoc Analysis of the TRIMARAN and TRIGGER Studies

Airflow Obstruction ◽

Glycopyrronium Bromide ◽

Post Hoc Analysis ◽

Post Hoc ◽

Effect of High ICS Dose Fixed Combination Extra Fine Beclomethasone Dipropionate, Formoterol Fumarate, and Glycopyrronium Bromide (BDP/FF/GB) on Lung Function in Asthmatics with Persistent Airflow Limitation (PAL): A Post-Hoc Analysis of the TRIGGER Study

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3005 ◽

2020 ◽

Author(s):

D. Singh ◽

G.W. Cononica ◽

J.C. Virchow ◽

M. Kots ◽

F. Zuccaro ◽

...

Keyword(s):

Lung Function ◽

Fixed Combination ◽

Airflow Limitation ◽

Glycopyrronium Bromide ◽

Post Hoc Analysis ◽

Post Hoc ◽

Effect of Medium ICS Dose Fixed Combination Extra Fine Beclomethasone Dipropionate, Formoterol Fumarate, and Glycopyrronium Bromide (BDP/FF/GB) pMDI on Lung Function in Asthmatics with Persistent Airflow Limitation (PAL): A Post-Hoc Analysis of the Trimaran Study

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3009 ◽

2020 ◽

Author(s):

J.C. Virchow ◽

G.W. Canonica ◽

D. Singh ◽

M. Kots ◽

S. Corre ◽

...

Keyword(s):

Lung Function ◽

Fixed Combination ◽

Airflow Limitation ◽

Glycopyrronium Bromide ◽

Post Hoc Analysis ◽

Post Hoc ◽

The efficacy of extrafine beclomethasone dipropionate–formoterol fumarate in COPD patients who are not "frequent exacerbators": a post hoc analysis of the FORWARD study

International Journal of Chronic Obstructive Pulmonary Disease ◽

10.2147/copd.s141416 ◽

2017 ◽

Vol Volume 12 ◽

pp. 3263-3271 ◽

Cited By ~ 2

Author(s):

Dave Singh ◽

Stefano Vezzoli ◽

Stefano Petruzzelli ◽

Alberto Papi

Keyword(s):

Post Hoc Analysis ◽

Copd Patients ◽

Post Hoc ◽

Lung deposition and distribution of inhaled extra fine beclomethasone dipropionate / formoterol fumarate /glycopyrronium bromide (BDP/FF/GB) in subjects with and without airflow obstruction

10.1183/13993003.congress-2021.pa3396 ◽

2021 ◽

Author(s):

Simonetta Baldi ◽

Omar Usmani ◽

Simon Warren ◽

Ilaria Panni ◽

Luca Girardello ◽

...

Keyword(s):

Airflow Obstruction ◽

Lung Deposition ◽

Glycopyrronium Bromide ◽

S27 Effect of high ICS dose fixed combination extrafine beclomethasone dipropionate, formoterol fumarate, and glycopyrronium (BDP/FF/G) pMDI on asthma control in patients with persistent airflow limitation (PAL): a post-hoc analysis of the TRIGGER study

10.1136/thorax-2020-btsabstracts.33 ◽

2021 ◽

Author(s):

D Singh ◽

JC Virchow ◽

WG Canonica ◽

G Georges ◽

A Vele ◽

...

Keyword(s):

Asthma Control ◽

Fixed Combination ◽

Airflow Limitation ◽

Post Hoc Analysis ◽

Post Hoc ◽

Pharmacokinetics of the Extrafine Fixed-Dose Combination of Beclomethasone Dipropionate, Formoterol Fumarate, Glycopyrronium Bromide Delivered Via a Pressurized-Metered Dose Inhaler (pMDI) in Chinese Subjects

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4527 ◽

2019 ◽

Author(s):

G. Georges ◽

Z. Luo ◽

G. Ciurlia ◽

P. Guller ◽

L. Girardello ◽

...

Keyword(s):

Fixed Dose Combination ◽

Fixed Dose ◽

Dose Inhaler ◽

Metered Dose Inhaler ◽

Glycopyrronium Bromide ◽

Metered Dose ◽

Dose Combination ◽

Chinese Subjects ◽

Comparison of a dry powder inhaler (DPI) to a pressurized metered-dose inhaler (pMDI) formulation of extra fine beclomethasone dipropionate/formoterol fumarate/glycopyrronium bromide (BDP/FF/GB) in patients with COPD: The TRI-D study

10.1183/13993003.congress-2020.3246 ◽

2020 ◽

Author(s):

Kai Michael Beeh ◽

Piotr Kuna ◽

Isabelle Viaud ◽

Alessandro Guasconi ◽

Massimo Corradi ◽

...

Keyword(s):

Dry Powder Inhaler ◽

Dose Inhaler ◽

Metered Dose Inhaler ◽

Dry Powder ◽

Glycopyrronium Bromide ◽

Metered Dose ◽

Pressurized Metered Dose Inhaler ◽

Asthma Control and Study Withdrawal in Patients With Versus Without Fixed Airflow Obstruction (2 Criteria): Post Hoc Analysis of a Budesonide/Formoterol Pressurized Metered-Dose Inhaler Study in Patients With Moderate to Severe Asthma

CHEST Journal ◽

10.1378/chest.1371955 ◽

2012 ◽

Vol 142 (4) ◽

pp. 686A

Author(s):

Donald Tashkin ◽

Bradley Chipps ◽

Tom Uryniak ◽

Frank Trudo ◽

James Zangrilli

Keyword(s):

Asthma Control ◽

Severe Asthma ◽

Airflow Obstruction ◽

Dose Inhaler ◽

Metered Dose Inhaler ◽

Post Hoc Analysis ◽

Metered Dose ◽

Pressurized Metered Dose Inhaler ◽

Post Hoc ◽

Fixed Airflow Obstruction

Benefits of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Patients with Chronic Obstructive Pulmonary Disease by Baseline CAT Score: Post-Hoc Analysis of the ETHOS Study

10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2246 ◽

2021 ◽

Author(s):

J. Hurst ◽

F.J. Martinez ◽

D. Singh ◽

P. Darken ◽

M. Patel ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Dose Inhaler ◽

Chronic Obstructive ◽

Metered Dose Inhaler ◽

Obstructive Pulmonary Disease ◽

Post Hoc Analysis ◽

Metered Dose ◽

Post Hoc ◽

Seasonal Variation in COPD Exacerbations: a Post-Hoc Analysis from the KRONOS Phase III Study of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI)

10.1055/s-0039-3403160 ◽

2020 ◽

Author(s):

KF Rabe ◽

LM Fabbri ◽

FJ Martinez ◽

GT Ferguson ◽

E Bourne ◽

...

Keyword(s):

Seasonal Variation ◽

Phase Iii ◽

Dose Inhaler ◽

Metered Dose Inhaler ◽

Post Hoc Analysis ◽

Copd Exacerbations ◽

Metered Dose ◽

Phase Iii Study ◽

Post Hoc ◽